Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,373 | -11,570 | -5,200 | -13,103 | -8,814 |
| Depreciation Amortization | 24 | 16 | 8 | 30 | 22 |
| Other Working Capital | -2,074 | -172 | 1,591 | 515 | -1,853 |
| Other Operating Activity | 1,006 | 677 | -122 | 953 | 544 |
| Operating Cash Flow | $-16,417 | $-11,049 | $-3,723 | $-11,604 | $-10,101 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,976 | 32 | 33 | 3,799 | 3,843 |
| Investing Cash Flow | $7,976 | $32 | $33 | $3,799 | $3,843 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,027 | 266 | 219 | 13,866 | 6,683 |
| Other Financing Activity | -17 | -14 | -10 | -30 | -21 |
| Financing Cash Flow | $3,010 | $253 | $209 | $13,836 | $6,662 |
| Exchange Rate Effect | -110 | -107 | -157 | -213 | 12 |
| Beginning Cash Position | 24,106 | 24,130 | 24,731 | 17,203 | 17,434 |
| End Cash Position | 18,564 | 13,258 | 21,094 | 23,021 | 17,850 |
| Net Cash Flow | $-5,542 | $-10,872 | $-3,638 | $5,818 | $416 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,417 | -11,049 | -3,723 | -11,604 | -10,101 |
| Free Cash Flow | -16,417 | -11,049 | -3,723 | -11,604 | -10,101 |